Intra-individual variability in cognitive performance predicts functional decline in Parkinson's disease
Jeremy J Davis1, Anjali Sivaramakrishnan2, Summer Rolin3
1Department of Neurology, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, UT Health San Antonio, San Antonio, TX, USA.
Applied Neuropsychology. Adult
|January 11, 2023
Summary
Cognitive intra-individual variability (IIV) in Parkinson's disease (PD) predicts functional ability. Higher IIV in PD patients is linked to greater functional impairment, highlighting its role in disease progression.
Area of Science:
- Neuroscience
- Gerontology
- Clinical Neurology
Background:
- Parkinson's disease (PD) is characterized by cognitive deficits contributing to disability.
- Cognitive intra-individual variability (IIV), a measure of cognitive fluctuation, is linked to cognitive decline in aging but its role in PD functional ability is unclear.
Purpose of the Study:
- To investigate the relationship between cognitive intra-individual variability (IIV) and functional ability in individuals with Parkinson's disease (PD).
Main Methods:
- Utilized de-identified data from 1,228 participants with PD and matched controls from the National Alzheimer's Coordinating Center.
- Assessed functional ability using the Functional Ability Questionnaire (FAQ) and cognitive function via the overall test battery mean (OTBM) and IIV.
- Employed logistic regression to predict baseline functional status, controlling for age, education, cognition, depression, and motor function.
Main Results:
- Participants with PD exhibited lower overall cognitive function (OTBM) and higher IIV, depression (GDS), and motor dysfunction compared to controls.
- Cognitive function (OTBM), IIV, depression (GDS), and gait were significant predictors of functional status, achieving 77% classification accuracy (AUC = .84).
- PD participants with functional impairment at follow-up showed significantly lower OTBM and higher IIV, GDS, and motor dysfunction at baseline.
Conclusions:
- Cognitive intra-individual variability (IIV) independently predicts functional status in Parkinson's disease (PD) patients, even after accounting for other clinical factors.
- Elevated IIV at baseline is associated with the presence of functional impairment in individuals with PD.
- IIV represents a potential biomarker for functional decline in Parkinson's disease.
Related Concept Videos
Parkinson's Disease: Overview
645
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
645
Neural Regulation
39.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.7K
Parkinson's Disease: Treatment
333
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
333
Cognitive Development During Adulthood
199
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
199
Alzheimer's Disease: Overview
600
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
600


